[[4-[[3-[2-[3-[[(1S)-2-[[2-[[(1S)-1-[[2-[[(1S)-5-amino-1-carbamoyl-pentyl]amino]-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]amino]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-3-oxo-propyl]sulfanylethylamino]-3-oxo-propyl]amino]-3-hydroxy-2,2-dimethyl-4-oxo-butoxy]-hydroxy-phosphoryl] [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

ID: ALA5081275

Chembl Id: CHEMBL5081275

PubChem CID: 166629785

Max Phase: Preclinical

Molecular Formula: C43H76N17O23P3S

Molecular Weight: 1324.17

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](OP(=O)(O)O)[C@@H]1O)C(O)C(=O)NCCC(=O)NCCSCCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O

Standard InChI:  InChI=1S/C43H76N17O23P3S/c1-43(2,20-80-86(77,78)83-85(75,76)79-19-26-32(66)33(82-84(72,73)74)41(81-26)60-22-56-31-35(45)54-21-55-37(31)60)34(67)40(71)50-12-8-27(62)49-13-15-87-14-9-28(63)59-25(18-61)39(70)53-17-30(65)58-24(7-5-11-51-42(47)48)38(69)52-16-29(64)57-23(36(46)68)6-3-4-10-44/h21-26,32-34,41,61,66-67H,3-20,44H2,1-2H3,(H2,46,68)(H,49,62)(H,50,71)(H,52,69)(H,53,70)(H,57,64)(H,58,65)(H,59,63)(H,75,76)(H,77,78)(H2,45,54,55)(H4,47,48,51)(H2,72,73,74)/t23-,24-,25-,26+,32+,33+,34?,41+/m0/s1

Standard InChI Key:  GXJAGZKFUWHSAH-IXIPRJPASA-N

Alternative Forms

  1. Parent:

    ALA5081275

    ---

Associated Targets(Human)

NAA40 Tbio N-alpha-acetyltransferase 40 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NAA50 Tchem N-alpha-acetyltransferase 50 (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT2B Tchem Histone acetyltransferase PCAF (884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KAT8 Tchem Histone acetyltransferase KAT8 (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1324.17Molecular Weight (Monoisotopic): 1323.4234AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Deng Y, Deng S, Ho YH, Gardner SM, Huang Z, Marmorstein R, Huang R..  (2021)  Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.,  64  (12.0): [PMID:34110812] [10.1021/acs.jmedchem.1c00141]

Source